Insider · CIK 0001632454

McCracken Joseph S

Reports to the SEC for 4 companies · LANGHORNE, PA

sec.gov

Transactions

Companies

Filings

CIK

0001632454

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-02-16	SVRASavara IncM Exercise/Conversion	Director	MExercise/Conversion	+1,807 sh	$1.76	+$3,180.32	302,644
2026-02-16	SVRASavara Inc · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,807 sh	—	—	0
2025-12-09	SVRASavara IncA Award	Director	AAward	+40K sh	—	—	300,837
2025-05-29	SVRASavara IncP Purchase	Director	PPurchase	+10K sh	$2.08	+$20.8K	260,837
2024-12-12	LUMOS PHARMA, INC.D Disposition to Issuer	Director	DDisposition to Issuer	−15.7K sh	—	—	0
2024-12-12	SVRASavara IncA Award	Director	AAward	+40K sh	—	—	250,837
2024-12-12	LUMOS PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−3,345 sh	—	—	0
2024-12-12	LUMOS PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−3,328 sh	—	—	0
2024-12-12	LUMOS PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,684 sh	—	—	0
2024-12-12	LUMOS PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−3,431 sh	—	—	0
2024-12-12	LUMOS PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,910 sh	—	—	0
2024-11-19	SVRASavara IncP Purchase	Director	PPurchase	+20K sh	$2.95	+$59.1K	210,837
2024-06-05	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Director	AAward	+3,328 sh	—	—	3,328
2023-12-14	SVRASavara IncA Award	Director	AAward	+22.5K sh	—	—	190,837
2023-05-10	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Director	AAward	+3,345 sh	—	—	3,345
2022-12-13	SVRASavara Inc · Stock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2022-11-16	LUMOS PHARMA, INC.P Purchase	Director	PPurchase	+4,000 sh	$5.03	+$20.1K	15,721
2022-08-25	LUMOS PHARMA, INC.P Purchase	Director	PPurchase	+3,170 sh	$8.60	+$27.3K	11,721
2022-05-05	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Director	AAward	+3,431 sh	—	—	3,431
2021-12-14	SVRASavara Inc · Stock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2021-08-27	Kindred Biosciences, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−48.5K sh	—	—	0
2021-08-27	Kindred Biosciences, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−48.5K sh	$4.81	−$233K	0
2021-08-27	Kindred Biosciences, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−48.5K sh	—	—	0
2021-08-27	Kindred Biosciences, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2021-08-27	Kindred Biosciences, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−41.9K sh	—	—	0
2021-08-11	LUMOS PHARMA, INC.P Purchase	Director	PPurchase	+7,475 sh	$7.55	+$56.4K	8,551
2021-05-20	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Director	AAward	+2,910 sh	—	—	2,910
2021-05-20	LUMOS PHARMA, INC.A Award	Director	AAward	+367 sh	—	—	1,076
2021-03-15	SVRASavara IncP Purchase	Director	PPurchase	+69K sh	$1.45	+$100K	168,337
2021-01-20	Kindred Biosciences, Inc.Stock Option (right to buy)A Award	Director	AAward	+48.5K sh	—	—	48,500
2020-12-16	SVRASavara Inc · Stock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2020-04-03	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Director	AAward	+5,684 sh	—	—	5,684
2020-04-03	LUMOS PHARMA, INC.A Award	Director	AAward	+709 sh	—	—	709
2020-01-17	Kindred Biosciences, Inc.Stock Option (right to buy)A Award	Director	AAward	+48.5K sh	—	—	48,500
2019-12-20	SVRASavara Inc · Stock Option (Right to Buy)A Award	Director	AAward	+12K sh	—	—	12,000
2019-07-05	SVRASavara IncM Exercise/Conversion	Director	MExercise/Conversion	+21.7K sh	$0.82	+$17.8K	81,548
2019-07-05	SVRASavara IncM Exercise/Conversion	Director	MExercise/Conversion	+2,930 sh	$0.82	+$2,402.6	84,478
2019-07-05	SVRASavara IncM Exercise/Conversion	Director	MExercise/Conversion	+5,860 sh	$1.46	+$8,555.6	90,338
2019-07-05	SVRASavara IncM Exercise/Conversion	Director	MExercise/Conversion	+9,034 sh	$1.76	+$15.9K	99,372
2019-07-05	SVRASavara Inc · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−21.7K sh	—	—	0
2019-07-05	SVRASavara Inc · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,930 sh	—	—	0
2019-07-05	SVRASavara Inc · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,860 sh	—	—	0
2019-07-05	SVRASavara Inc · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−9,034 sh	—	—	1,807
2019-02-01	Kindred Biosciences, Inc.Stock Option (right to buy)A Award	Director	AAward	+48.5K sh	—	—	48,500
2018-12-13	SVRASavara Inc · Stock Option (Right to Buy)A Award	Director	AAward	+12K sh	—	—	12,000
2018-06-22	Kindred Biosciences, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2018-04-20	Kindred Biosciences, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+41.9K sh	—	—	41,890
2017-12-17	SVRASavara Inc · Stock Option (Right to Buy)A Award	Director	AAward	+3,750 sh	—	—	3,750
2017-07-31	Nexvet Biopharma plcD Disposition to Issuer	Director	DDisposition to Issuer	−16.4K sh	$6.72	−$110K	0
2017-07-01	Nexvet Biopharma plcM Exercise/Conversion	Director	MExercise/Conversion	+3,600 sh	$0.13	+$450	16,400

Recent filings

Accepted (ET)
Feb 174
McCracken Joseph S0001193125-26-055175
SEC(opens sec.gov)
Dec 114
McCracken Joseph S0001193125-25-316296
SEC(opens sec.gov)
Jun 24
McCracken Joseph S0000950170-25-080021
SEC(opens sec.gov)
Dec 164
McCracken Joseph S0000950170-24-136770
SEC(opens sec.gov)
Dec 134
McCracken Joseph S0001126234-24-000111
SEC(opens sec.gov)
Nov 204
McCracken Joseph S0000950170-24-129007
SEC(opens sec.gov)
Jun 74
McCracken Joseph S0001126234-24-000077
SEC(opens sec.gov)
Dec 154
McCracken Joseph S0001209191-23-058841
SEC(opens sec.gov)
May 124
McCracken Joseph S0001126234-23-000071
SEC(opens sec.gov)
Dec 154
McCracken Joseph S0001209191-22-061424
SEC(opens sec.gov)
Nov 184
McCracken Joseph S0001126234-22-000114
SEC(opens sec.gov)
Aug 264
McCracken Joseph S0001126234-22-000092
SEC(opens sec.gov)
May 94
McCracken Joseph S0001126234-22-000055
SEC(opens sec.gov)
Dec 144
McCracken Joseph S0001209191-21-069585
SEC(opens sec.gov)

Companies

Address

ONE SUMMIT SQUARE, 1717 LANGHORNE NEWTOWN ROAD, SUITE 300

LANGHORNE, PA, 19047